NovaBridge Biosciences Income Statement (2017-2025) | NBP

Income Statement Dec2017 Dec2018 Sep2019 Dec2019 Jun2020 Sep2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
0.00B0.00B0.00B0.00B
Operating items
Research & Development (Quarter)
-0.04B0.20B-0.10B0.33B0.03B-0.00B-0.01B0.03B-0.01B-0.01B-0.00B0.01B-0.00B-0.00B0.01B0.06B
Selling, General & Administrative (Quarter)
-0.00B0.18B-0.04B-0.01B-0.01B-0.01B0.05B-0.00B-0.01B-0.01B0.05B-0.00B-0.00B-0.01B0.05B
Other Operating Expenses (Quarter)
-0.07B-0.01B-0.17B
Operating Expenses (Quarter)
-0.05B0.38B-0.15B0.32B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.07B
Operating Income (Quarter)
-0.04B-0.05B88.52B0.18B-0.01B-0.01B-0.04B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.07B
EBIT (Quarter)
-0.04B-0.05B88.52B0.18B-0.01B-0.01B-0.04B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.07B
Non-operating items
Interest & Investment Income (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.00B0.00B0.01B0.00B0.00B0.01B
Other Non Operating Income (Quarter)
0.00B-0.00B0.06B-0.00B-0.01B0.00B0.00B-0.00B
Non Operating Income (Quarter)
-0.02B0.00B0.00B-0.00B0.01B-0.01B0.00B0.00B-0.00B
Net income details
EBT (Quarter)
-0.04B-0.05B-0.08B0.16B-0.03B-0.01B-0.04B-0.01B-0.01B-0.02B-0.01B-0.00B-0.01B-0.01B-0.07B
Tax Provisions (Quarter)
-0.00B
Profit After Tax (Quarter)
0.28B-0.36B0.17B-0.02B-0.06B0.03B0.07B-0.02B0.03B-0.02B0.01B-0.00B-0.01B-0.01B-0.07B
Equity Income (Quarter)
0.00B-0.06B0.01B-0.00B-0.00B0.02B-0.00B0.00B
Income from Continuing Operations (Quarter)
-0.04B-0.05B-0.08B0.16B-0.03B-0.01B-0.04B-0.01B-0.01B-0.02B-0.01B-0.00B-0.01B-0.01B-0.07B
Consolidated Net Income (Quarter)
-0.04B-0.05B-0.08B0.16B-0.03B-0.03B-0.01B0.03B0.03B-0.03B-0.00B-0.01B-0.01B-0.07B
Income towards Parent Company (Quarter)
-0.04B-0.05B-0.08B0.16B-0.03B-0.01B0.03B0.03B-0.03B-0.00B-0.01B-0.01B-0.07B
Net Income towards Common Stockholders (Quarter)
-0.04B-0.05B-0.08B0.16B-0.06B0.03B-0.01B0.03B-0.02B-0.03B-0.00B-0.01B-0.01B-0.07B
Additional items
EPS (Basic) (Quarter)
-51.70-0.780.00B-0.320.17-0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.33
EPS (Weighted Average and Diluted) (Quarter)
-51.700.00B-2.25-0.040.00B-0.00B-0.02-0.00B-0.00B-0.33
Shares Outstanding (Weighted Average) (Quarter)
0.00B0.02B0.02B529.640.03B0.03B0.03B0.19B0.19B0.03B50.00100.00210.00120.0020.0050.0080.000.22B
Shares Outstanding (Diluted Average) (Quarter)
0.00B0.02B452.680.03B0.03B0.03B0.03B0.03B0.03B0.19B110.00140.000.19B110.00170.000.22B
EBITDA (Quarter)
-0.04B-0.05B88.52B0.18B-0.01B-0.01B-0.04B0.02B0.03B-0.00B-0.04B-0.00B-0.00B0.01B-0.09B
Interest Expenses (Quarter)
-0.00B0.00B-0.00B
Tax Rate (Quarter)
-1.16%